Bartholin gland carcinoma is an extremely rare disease. Information regarding treatment is scarce and there is no strict consensus on best practice. All studies reporting cases of Bartholin’s gland cancer were screened and evaluated for inclusion. Baseline characteristics of studies were extracted. A total number of 290 manuscripts collected were available for the review process. Studies included in a previous systematic review were not duplicated. In total, details of 367 patients were collected, as follows: histological features, clinical presentation, treatment, recurrent rate, treatment of recurrence and outcome. About 35% of Bartholin gland carcinoma were squamous cell carcinoma. Almost 50% of patients presented with advanced stage. The therapeutic approach was mainly surgery, and in 61% of those women lymph node assessment was performed. Recurrence occurred in 21% of cases. Bartholin gland cancer remains a challenge for gynecologic oncologists. Guidelines, centralization to referral centers and standardized therapy are needed.
OuldamerLChraibiZArbionF, et al. Bartholin's gland carcinoma: epidemiology and therapeutic management. Surg Oncol2013; 22: 117-122.
2.
JemalASimardEPDorellC, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst2013; 105: 175–201.
HonanJ.Uber die Carcinome der Glandulae Bartholini.University of Berlin, Inaugural Dissertation 1989.
5.
ChamlianDLTaylorHB.Primary carcinoma of Bartholin’s gland. A report of 24 patients. Obstet Gynecol1972; 39: 489–494.
6.
Di DonatoVCasorelliABardhiE, et al. Bartholin gland cancer. Crit Rev Oncol Hematol2017; 117: 1–11.
7.
WangKZhengYTongL, et al. Analysis of clinical outcomes of patients with primary rare carcinoma of Bartholin gland: six case series report and review of the literature. Transl Cancer Res2022; 11: 1483–1487.
RamanahRAllam-NdoulEBaezaC, et al. Brain and lung metastasis of Bartholin’s gland adenoid cystic carcinoma: a case report. J Med Case Rep2013; 7: 208.
10.
ZhanPLiGLiuB, et al. Bartholin gland carcinoma: A case report. Oncol Lett2014; 8: 849–851.
11.
YoonGKimHSLeeYY, et al. Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands. Int J Clin Exp Pathol2015; 8: 5688–5694.
12.
BhalwalABNickAMDos ReisR, et al. Carcinoma of the bartholin gland: A review of 33 cases. Int J Gynecol Cancer2016; 26: 785–789.
13.
MomeniMKorotkayaYCarrascoG, et al. Adenoid cystic carcinoma of Bartholin’s gland. Acta Med Iran2016; 54: 54–58.
14.
JohnsonLRNairRPSambasivanS, et al. Adenoid cystic carcinoma of vulva-11 years’ single-institution experience. J Obstet Gynecol India2017; 67: 196–201.
15.
BernhardtDSterzingFAdebergS, et al. Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: A case series. Cancer Manag Res2018; 10: 583–588.
16.
GohSPMcCullyBWagnerMK.A case of adenoid cystic carcinoma mimicking a Bartholin cyst and literature review. Case Rep Obstet Gynecol2018; 2018: 1–3.
17.
WuJCXiMLWangYQ, et al. Primary small cell neuroendocrine carcinoma of the Bartholin’s gland: A case report. Oncol Lett2018; 16: 4434–4438.
18.
BillingsleyCJacksonALoreenA.29-year-old with dyspareunia and vulvar mass: An unusual diagnosis of Bartholin’s gland carcinoma. Gynecol Oncol Reports2019; 27: 15–18.
19.
BlontzosNIavazzoCGiovannopoulouE, et al. Recurrence of Bartholin gland mucinous adenocarcinoma managed with posterior exenteration: a case report. J Obstet Gynaecol (Lahore)2020; 40: 1029–030.
20.
ChangYWuWChenH.Adenoid cystic carcinoma of the Bartholin’s gland: a case report and literature review. J Int Med Res2019; 48(2): 1–5.
21.
LoCCWLeowJBYNaingK, et al. Adenoid cystic carcinoma of the Bartholin’s gland: A diagnostic dilemma. Case Rep Obstet Gynecol2019; 2019: 1–4.
22.
NazeranTChengASKarnezisAN, et al. Bartholin gland carcinoma: clinicopathologic features, including p16 expression and clinical outcome. Int J Gynecol Pathol2019; 38: 189-195.
23.
YangFLiHQiX, et al. Post-hysterectomy rare collision vulva tumor with long-term human papilloma virus infection composed of squamous cell carcinoma of the labia major and adenosquamous carcinoma of bartholin gland: A case report. Med (United States)2019; 98:39: 1–4.
24.
YoshidaH.Surgical treatment for locally advanced adenoid cystic carcinoma of the bartholin’s gland: A case report. Tokai J Exp Clin Med2019; 44: 68–72.
25.
AkerSŞErsözCCOrtaçF. Adenoid cystic carcinoma of bartholin’s gland diagnosed after lung lobectomy: Review of the literature and a case presentation. Turkish J Obstet Gynecol2020; 17: 310–313.
26.
JamshidiAMEichbergDGGultekinS, et al. Brain metastasis from Bartholin gland carcinoma. World Neurosurg2020; 143: 280–284.
27.
KhanRSAbbasiHS.A different strategy for management of a case of adenoid cystic carcinoma of Bartholin gland. J Pak Med Assoc2020; 70: 1445–1447.
28.
NakamuraKAimonoETanishimaS, et al. Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin’s glands reveals potential new routes for targeted therapies: A case report. Diagn Pathol2020; 15: 4–8.
29.
Nieuwenhuyzen-de BoerGMDasguptaSEwing-GrahamPC, et al. Adenoid cystic carcinoma of the Bartholin gland is not HPV-related: A case report and review of literature. Pathol Res Pract2020; 216: 152968.
30.
SantiagoAETeunissenNRicardoBFDP, et al. High-grade transformation in adenoid cystic carcinoma of the Bartholin gland: case report. Rev Bras Ginecol e Obstet2021; 43: 980–984.
31.
AkhtarMChishtiUIdressR.Bartholin gland carcinoma in a young female: A rare disease in an unusual age group. BMJ Case Rep2021; 14: 2020–2022.
32.
HanLZhengAChenYL.A rare case of primary small cell neuroendocrine carcinoma of the Bartholin gland. Int J Gynecol Obstet2021; 155: 539–540.
33.
HelmiZGhani NoriWZghairMAAbdulrahman HadiBAl. Bartholin gland carcinoma: A case report. J Pak Med Assoc2021; 71: S86–8.
34.
LubisLDDinaSKhaidirmanDK.Primary Bartholin adenocarcinoma: a rare case and radiotherapy as definitive treatment. Folia Med (Plovdiv)2021; 63: 985–989.
35.
MacciòADonisiCSannaE, et al. Next-generation sequencing whole-genome analysis for targeted treatment approach of metastatic bartholin gland adenocarcinoma: An emblematic case report and review of the literature. Diagnostics2021; 11, 2085: 1–12.
36.
Martín-VallejoJMolina-BellidoPLaforgaJB, et al. Intestinal-type adenocarcinoma of the Bartholin gland: A case report and literature review. Gynecol Oncol Reports2021; 37, 110836: 1–4.
37.
RobinsonHKarpeMEdidiI, et al. Enteric type bartholin gland adenocarcinoma: An unusual variant of a rare neoplasm. Int J Gynecol Pathol2021; 40: 190–195.
38.
Segarra VidalBCañete MotaSAndrade CadenaP, et al. Adenoid cystic carcinoma of the Bartholin’s gland. Int J Gynecol Cancer2021; 31: 292–298.
39.
UlmerKMcDonaldMEKowalskiJT.Case report: Biologic graft placement with subsequent radiation therapy following radical vulvectomy for adenoid cystic carcinoma of the Bartholin’s gland. Gynecol Oncol Reports2021; 36: 100736.
40.
VertaSChristmannCBrambsCE.Adenoid cystic carcinoma of Bartholin’s gland: a case report with emphasis on surgical management. Am J Case Rep2022; 23: 1–17.
41.
AddleySSadeghiNSmythSL, et al. Bartholin's gland carcinoma-the diagnostic and management challenges of a rare malignancy-a case report and review of current literature. Transl Cancer Res. 2023; 12: 201-208.
42.
LeeMYDalpiazASchwambR, et al. Clinical pathology of Bartholin's glands: a review of the literature. Curr Urol2015; 8: 22–25
43.
HellerDSBeanS.Lesions of the Bartholin gland: a review. J Low Genit Tract Dis. 2014; 18: 351-357.
44.
MazouniCMoricePDuvillardP, et al. Contralateral groin recurrence in patients with stage I Bartholin's gland squamous cell carcinoma and negative ipsilateral nodes: report on two cases and implications for lymphadenectomy. Gynecol Oncol2004; 94: 843-845.
45.
KraemerBGuengoerESolomayerEF, et al. Stage I carcinoma of the Bartholin’s gland managed with the detection of inguinal and pelvic sentinel lymph node. Gynecol. Oncol2009; 114: 373–374
46.
WilliamsPLBannisterLHBerryMM, et al. Gray’s Anatomy, 38th ed. New York: Churchill Livingstone, 1995.
47.
FetissofFArbeilleBBelletD, et al. Endocrine cells in human Bartholin’s glands: an immunohistochemical and ultrastructural analysis. Virchows Arch B Cell Pathol Incl Mol Phatol1989; 57: 117–121.
48.
PuppoV.Embryology and anatomy of the vulva: the female orgasm and women’s sexual health. Eur J Obstet Gynecol Reprod Biol2011; 154(1): 3–8
TopolovecZBlažičevićVŠijanovićS, et al. Squamous cell carcinoma of Bartholin gland coexistent with human papillomavirus. Eur J Gynaecol Oncol2015; 36: 482-484.
51.
ViciPMarianiLPizzutiL, et al. Immunologic treatments for precancerous lesions and uterine cervical cancer. J Exp Clin Cancer Res. 2014; 33: 29.
52.
KowWJAbu-RustumNRBeanS, et al. NCCN Clinical Practice Guidelines in Oncology - Vulvar Cancer Squamous Cell Carcinoma. Version 2. J Natl Compr Canc Netw. 2017; 15(1): 92–120.
53.
OonkMHMPlanchampFBaldwinP, et al. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023. Int J Gynecologic Cancer2023; 33: 1023-1043.
54.
VirarkarMVulasalaSSDaoudT, et al. Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging. Cancers2022; 14: 2264.
55.
Di DonatoVPageZBracchiC, et al. The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients. J Gynecol Oncol2019; 30:e6.
56.
TockSWalletJBelhadiaM, et al. Outcomes of the use of different vulvar flaps for reconstruction during surgery for vulvar cancer. Eur J Surg Oncol2019; 45: 1625-1631.
57.
De MooijYBurgerMPSchilthuisMS, et al. Partial urethral resection in the surgical treatment of vulvar cancer does not have a significant impact on urinary continence. A confirmation of an authority-based opinion. Int J Gynecologic Cancer2007; 17: 294-297.
58.
Benedetti PaniciPDi DonatoVBracchiC, et al. Modified gluteal fold advancement V-Y flap for vulvar reconstruction after surgery for vulvar malignancies. Gynecologic Oncol2014; 132: 125–129.
59.
TomaoFDomeniciLPaniciPB.Is removing 9 lymph nodes a correct cutoff to define optimal lymphadenectomy?: The open question of lymph node count. Int J Gynecol Cancer2014; 24: 1358.
60.
Benedetti PaniciPTomaoFDomeniciL, et al. Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review. Gynecologic Oncol2015; 137: 373–379.
CardosiRJSpeightsAFioricaJV, et al. Bartholin’s gland carcinoma: a 15-year experience. Gynecologic Oncol2001; 82: 247–251.
63.
ObermalrARollerSCrandonAJ, et al. Primary Bartholin gland carcinoma: a report of seven cases. Aust N Z J Obstet Gynaecol2001; 41: 78–81.
64.
López-VarelaEOlivaEMcIntyreJF, et al. Primary treatment of Bartholin's gland carcinoma with radiation and chemoradiation: a report on ten consecutive cases. Int J Gynecological Cancer2007; 17: 661–667.
65.
HamplMHantschmannPMichelsW, et al. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecologic Oncol2008; 111: 282–288.
66.
OonkMHMSlomovitzBBaldwinPJW, et al. Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: Results of GROINSS-V II. J Clin Oncol2021; 39: 3623–3632.
67.
Van BeekhuizenHJAuzinMvan den EindenLC, et al. Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer. Int J Gynecol Cancer2014; 24: 773-778.
68.
ColemanRLAliSLevenbackCF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol2013; 128: 155-9.
69.
GaoYLiHLiC.Neoadjuvant chemotherapy followed by radical vulvectomy for adenoid cystic carcinoma of Bartholin's gland: a case report. Translat Cancer Res2022; 11: 3883–3889.
70.
MazzottaMPizzutiLKrasniqiE, et al. Role of chemotherapy in vulvar cancers: time to rethink standard of care?Cancers (Basel)2021; 13: 4061.
71.
TomaoFDi TucciCMarchettiC, et al. Role of chemotherapy in the management of vulvar carcinoma. Crit Rev Oncol Hematol2012; 82: 25-39.
72.
AlsanC IVinh-HungVErenF, et al. Adenoid cystic carcinoma of the Bartholin's gland: case report and systematic review of the literature. Eur J Gynaecological Oncol2011; 32: 567–572.
73.
BoganiGCromiASeratiM, et al. Predictors and patterns of local, regional, and distant failure in squamous cell carcinoma of the vulva. Am J Clin Oncol2017; 40: 235–240.
74.
PalaiaIBellatiFCalcagnoM, et al. Invasive vulvar carcinoma and the question of the surgical margin. Int J Gynaecol Obstetrics2011; 114: 120–123.
75.
PaniciPBTomaoFDomeniciL, et al. Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review. Gynecol Oncol2015; 137: 373-379.
76.
JagerLNilssonLRådestadAF.Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution. Int J Gynecological Cancer2013; 23: 755–762.
77.
Blontzos BlontzosNIavazzoCGiovannopoulouE, et al. Recurrence of Bartholin gland mucinous adenocarcinoma managed with posterior exenteration: a case report. J Obstetrics Gynaecol2019; 40(7): 1029–1030.
78.
MatsuoKKlarMNishioS, et al. Validation of the 2021 FIGO staging schema for advanced vulvar cancer. Int J Gynecol Cancer2022; 32: 474–479.
79.
GarganeseGInzaniFFragomeniSM, et al. The Vulvar Immunohistochemical Panel (VIP) Project: Molecular profiles of vulvar squamous cell carcinoma. Cancers (Basel)2021; 13: 6373.
80.
PrieskeKAlawiMJaegerA, et al. Transcriptome analysis in vulvar squamous cell cancer. Cancers (Basel)2021; 13 : 6372.
81.
MantovaniGFragomeniSMInzaniF, et al. Molecular pathways in vulvar squamous cell carcinoma: implications for target therapeutic strategies. J Cancer Res Clin Oncol2020; 146: 1647–1658.
82.
BoganiGPalaiaIPerniolaG, et al. An update on current pharmacotherapy for vulvar cancer. Exp Op Pharmacotherapy2023; 24: 95-103.
83.
HorowitzNSOlawaiyeABBorgerDR, et al. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol2012; 127: 141-146.
84.
HowJAJazaeriAASolimanPT, et al. Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial. Sci Rep2011; 11: 3667.
85.
CocksMMMillsAM.The Immune Checkpoint Inhibitor LAG-3 and Its Ligand GAL-3 in Vulvar Squamous Neoplasia. Int J Gynecological Pathol2022; 41: 113–121.
86.
BellatiFNapoletanoCTarquiniE, et al. Cancer testis antigen expression in primary and recurrent vulvar cancer: association with prognostic factors. Eur J Cancer2007; 43: 2621–2627.
